Drug induces morphologic, molecular, clinical remissions in myelofibrosis
Friday, December 6, 2013 - 15:32
in Health & Medicine
Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a study has found.